Zydus gets USFDA's nod for antipsychotic drug, stock flat
Pimavanserin is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson disease psychosis.
Source: moneycontrol.com
Lacosamide Tablets News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Lacosamide Tablets. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Lacosamide Tablets Today - Breaking & Trending Today
zydus lifesciences: Zydus Lifesciences gets USFDA nod to sell generic anti-epileptic medication
Zydus Lifesciences has received approval from the US FDA to market Lacosamide Tablets, a generic anti-epileptic medication used to treat partial-onset seizures and primary generalized tonic-clonic seizures. The product will be manufactured at the company's manufacturing facility in Ahmedabad.
Source: indiatimes.com
Zydus Lifesciences gets USFDA nod to sell generic anti-epileptic medication
Lacosamide is indicated to treat partial-onset seizures.
Source: indianexpress.com
Breckenridge Pharmaceutical, Inc. Announces Launch of Lacosamide Tablets, USP (generic version of Vimpat®) Manufactured by MSN Laboratories Private Limited
/PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announces that it has launched Lacosamide Tablets, USP (generic version of Vimpat®). The product was...
Source: prnewswire.com
Glenmark Pharmaceuticals receives ANDA approval for Lacosamide Tablets USP, 50 mg, 100 mg, 150 mg and 200 mg
Mumbai (Maharashtra) [India], March 21 (ANI/PR Newswire): Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S
Source: webindia123.com